RxDoctor Payments Data

Syed Mumtaz

Psychiatry · Alton, ILNPI 1902995798

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 45.0% of the total.

$1,695in general payments, 2019–2025

Across 122 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$763
  • AbbVie$296
  • Johnson & Johnson$164
  • Neos Therapeutics, LP$107
  • Otsuka America Pharmaceutical, Inc.$104
  • Sunovion Pharmaceuticals Inc.$101
  • plus $160 from 8 others
$4,496in research payments, 2019–2025

Across 5 payments — averaging $899.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$4K

What the payments were for

  • Food & beverage$1,688100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,695 in reported general payments places this provider in the 80th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Other psychiatry in Alton

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →